ReP USP - Resultado da busca

Artigo de periodico
Cannabinoid-based therapies and brain development: potential harmful effect of early modulation of the endocannabinoid system (2018)
Schonhofen, Patrícia; Bristot, Ivi Juliana; Crippa, José Alexandre de Souza; Hallak, Jaime Eduardo Cecílio; Zuardi, Antônio Waldo; Parsons, Richard B.; Klamt, Fábio
Source: CNS Drugs. Unidade: FMRP
Subjects: CANNABIS, TERAPÊUTICA MÉDICA, SISTEMA NERVOSO CENTRAL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SCHONHOFEN, Patrícia et al. Cannabinoid-based therapies and brain development: potential harmful effect of early modulation of the endocannabinoid system. CNS Drugs, v. 32, n. 8, p. 697-712, 2018Tradução . . Disponível em: https://doi.org/10.1007/s40263-018-0550-4. Acesso em: 31 out. 2024.
APA
Schonhofen, P., Bristot, I. J., Crippa, J. A. de S., Hallak, J. E. C., Zuardi, A. W., Parsons, R. B., & Klamt, F. (2018). Cannabinoid-based therapies and brain development: potential harmful effect of early modulation of the endocannabinoid system. CNS Drugs, 32( 8), 697-712. doi:10.1007/s40263-018-0550-4
NLM
Schonhofen P, Bristot IJ, Crippa JA de S, Hallak JEC, Zuardi AW, Parsons RB, Klamt F. Cannabinoid-based therapies and brain development: potential harmful effect of early modulation of the endocannabinoid system [Internet]. CNS Drugs. 2018 ; 32( 8): 697-712.[citado 2024 out. 31 ] Available from: https://doi.org/10.1007/s40263-018-0550-4
Vancouver
Schonhofen P, Bristot IJ, Crippa JA de S, Hallak JEC, Zuardi AW, Parsons RB, Klamt F. Cannabinoid-based therapies and brain development: potential harmful effect of early modulation of the endocannabinoid system [Internet]. CNS Drugs. 2018 ; 32( 8): 697-712.[citado 2024 out. 31 ] Available from: https://doi.org/10.1007/s40263-018-0550-4
Artigo de periodico
Translational investigation of the therapeutic potential of cannabidiol (CBD): toward a new age (2018)
Crippa, José Alexandre de Souza; Guimarães, Francisco Silveira; Campos, Alline Cristina de; Zuardi, Antônio Waldo
Source: Frontiers in Immunology. Unidade: FMRP
Subjects: CANABINOIDES, NEUROPSIQUIATRIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CRIPPA, José Alexandre de Souza et al. Translational investigation of the therapeutic potential of cannabidiol (CBD): toward a new age. Frontiers in Immunology, v. 9, 2018Tradução . . Disponível em: https://doi.org/10.3389/fimmu.2018.02009. Acesso em: 31 out. 2024.
APA
Crippa, J. A. de S., Guimarães, F. S., Campos, A. C. de, & Zuardi, A. W. (2018). Translational investigation of the therapeutic potential of cannabidiol (CBD): toward a new age. Frontiers in Immunology, 9. doi:10.3389/fimmu.2018.02009
NLM
Crippa JA de S, Guimarães FS, Campos AC de, Zuardi AW. Translational investigation of the therapeutic potential of cannabidiol (CBD): toward a new age [Internet]. Frontiers in Immunology. 2018 ; 9[citado 2024 out. 31 ] Available from: https://doi.org/10.3389/fimmu.2018.02009
Vancouver
Crippa JA de S, Guimarães FS, Campos AC de, Zuardi AW. Translational investigation of the therapeutic potential of cannabidiol (CBD): toward a new age [Internet]. Frontiers in Immunology. 2018 ; 9[citado 2024 out. 31 ] Available from: https://doi.org/10.3389/fimmu.2018.02009
Artigo de periodico
Novel insights into mitochondrial molecular targets of iron-induced neurodegeneration: reversal by cannabidiol (2018)
Silva, Vanessa Kappel da; Freitas, Betânia Souza de; Dornelles, Victória Campos; Kist, Luiza Wilges; Bogo, Maurício Reis; Silva, Milena Carvalho; Streck, Emílio Luiz; Hallak, Jaime Eduardo Cecílio; Zuardi, Antônio Waldo; Crippa, José Alexandre de Souza; Schröder, Nadja
Source: Brain Research Bulletin. Unidade: FMRP
Subjects: CANABINOIDES, MITOCÔNDRIAS, DNA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Vanessa Kappel da et al. Novel insights into mitochondrial molecular targets of iron-induced neurodegeneration: reversal by cannabidiol. Brain Research Bulletin, v. 139, p. 1-8, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.brainresbull.2018.01.014. Acesso em: 31 out. 2024.
APA
Silva, V. K. da, Freitas, B. S. de, Dornelles, V. C., Kist, L. W., Bogo, M. R., Silva, M. C., et al. (2018). Novel insights into mitochondrial molecular targets of iron-induced neurodegeneration: reversal by cannabidiol. Brain Research Bulletin, 139, 1-8. doi:10.1016/j.brainresbull.2018.01.014
NLM
Silva VK da, Freitas BS de, Dornelles VC, Kist LW, Bogo MR, Silva MC, Streck EL, Hallak JEC, Zuardi AW, Crippa JA de S, Schröder N. Novel insights into mitochondrial molecular targets of iron-induced neurodegeneration: reversal by cannabidiol [Internet]. Brain Research Bulletin. 2018 ; 139 1-8.[citado 2024 out. 31 ] Available from: https://doi.org/10.1016/j.brainresbull.2018.01.014
Vancouver
Silva VK da, Freitas BS de, Dornelles VC, Kist LW, Bogo MR, Silva MC, Streck EL, Hallak JEC, Zuardi AW, Crippa JA de S, Schröder N. Novel insights into mitochondrial molecular targets of iron-induced neurodegeneration: reversal by cannabidiol [Internet]. Brain Research Bulletin. 2018 ; 139 1-8.[citado 2024 out. 31 ] Available from: https://doi.org/10.1016/j.brainresbull.2018.01.014
Artigo de periodico
Maternal administration of cannabidiol promotes an anti-inflammatory effect on the intestinal wall in a gastroschisis rat model (2018)
Callejas, G. H.; Figueira, R. L.; Gonçalves, F. L. L.; Volpe, F. A. P.; Zuardi, Antônio Waldo; Crippa, José Alexandre de Souza; Hallak, Jaime Eduardo Cecílio; Sbragia, Lourenço
Source: Brazilian Journal of Medical and Biological Research. Unidade: FMRP
Subjects: CANABINOIDES, DIAGNÓSTICO PRÉ-NATAL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CALLEJAS, G. H. et al. Maternal administration of cannabidiol promotes an anti-inflammatory effect on the intestinal wall in a gastroschisis rat model. Brazilian Journal of Medical and Biological Research, v. 51, n. 5, 2018Tradução . . Disponível em: https://doi.org/10.1590/1414-431x20177132. Acesso em: 31 out. 2024.
APA
Callejas, G. H., Figueira, R. L., Gonçalves, F. L. L., Volpe, F. A. P., Zuardi, A. W., Crippa, J. A. de S., et al. (2018). Maternal administration of cannabidiol promotes an anti-inflammatory effect on the intestinal wall in a gastroschisis rat model. Brazilian Journal of Medical and Biological Research, 51( 5). doi:10.1590/1414-431x20177132
NLM
Callejas GH, Figueira RL, Gonçalves FLL, Volpe FAP, Zuardi AW, Crippa JA de S, Hallak JEC, Sbragia L. Maternal administration of cannabidiol promotes an anti-inflammatory effect on the intestinal wall in a gastroschisis rat model [Internet]. Brazilian Journal of Medical and Biological Research. 2018 ; 51( 5):[citado 2024 out. 31 ] Available from: https://doi.org/10.1590/1414-431x20177132
Vancouver
Callejas GH, Figueira RL, Gonçalves FLL, Volpe FAP, Zuardi AW, Crippa JA de S, Hallak JEC, Sbragia L. Maternal administration of cannabidiol promotes an anti-inflammatory effect on the intestinal wall in a gastroschisis rat model [Internet]. Brazilian Journal of Medical and Biological Research. 2018 ; 51( 5):[citado 2024 out. 31 ] Available from: https://doi.org/10.1590/1414-431x20177132
Artigo de periodico
Antiapoptotic effects of cannabidiol in an experimental model of cognitive decline induced by brain iron overload (2018)
Silva, Vanessa Kappel da; Freitas, Betânia Souza de; Garcia, Rebeca Carvalho Lacerda; Monteiro, Ricardo Tavares; Hallak, Jaime Eduardo Cecílio ; Zuardi, Antônio Waldo; Crippa, José Alexandre de Souza; Schröder, Nadja
Source: Translational Psychiatry. Unidade: FMRP
Subjects: CANABINOIDES, COGNIÇÃO, FERRO, MEMÓRIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Vanessa Kappel da et al. Antiapoptotic effects of cannabidiol in an experimental model of cognitive decline induced by brain iron overload. Translational Psychiatry, v. 8, n. 1, 2018Tradução . . Disponível em: https://doi.org/10.1038/s41398-018-0232-5. Acesso em: 31 out. 2024.
APA
Silva, V. K. da, Freitas, B. S. de, Garcia, R. C. L., Monteiro, R. T., Hallak, J. E. C., Zuardi, A. W., et al. (2018). Antiapoptotic effects of cannabidiol in an experimental model of cognitive decline induced by brain iron overload. Translational Psychiatry, 8( 1). doi:10.1038/s41398-018-0232-5
NLM
Silva VK da, Freitas BS de, Garcia RCL, Monteiro RT, Hallak JEC, Zuardi AW, Crippa JA de S, Schröder N. Antiapoptotic effects of cannabidiol in an experimental model of cognitive decline induced by brain iron overload [Internet]. Translational Psychiatry. 2018 ; 8( 1):[citado 2024 out. 31 ] Available from: https://doi.org/10.1038/s41398-018-0232-5
Vancouver
Silva VK da, Freitas BS de, Garcia RCL, Monteiro RT, Hallak JEC, Zuardi AW, Crippa JA de S, Schröder N. Antiapoptotic effects of cannabidiol in an experimental model of cognitive decline induced by brain iron overload [Internet]. Translational Psychiatry. 2018 ; 8( 1):[citado 2024 out. 31 ] Available from: https://doi.org/10.1038/s41398-018-0232-5
Artigo de periodico
Correction: Fluorinated cannabidiol derivatives: enhancement of activity in mice models predictive of anxiolytic, antidepressant and antipsychotic effects (2016)
Breuer, Aviva; Haj, Christeene G.; Fogaça, Manoela V.; Gomes, Felipe V.; Silva, Nicole Rodrigues; Pedrazzi, João Francisco; Del Bel, Elaine Aparecida; Hallak, Jaime Eduardo Cecílio; Crippa, José Alexandre de Souza; Zuardi, Antônio Waldo; Mechoulam, Raphael; Guimarães, Francisco Silveira
Source: PLOS ONE. Unidades: FORP, FMRP
Subjects: CANABINOIDES, FLUORAÇÃO, NEUROPSIQUIATRIA, FARMACOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BREUER, Aviva et al. Correction: Fluorinated cannabidiol derivatives: enhancement of activity in mice models predictive of anxiolytic, antidepressant and antipsychotic effects. PLOS ONE, v. 11, n. 8, 2016Tradução . . Disponível em: https://doi.org/10.1371/journal.pone.0162087. Acesso em: 31 out. 2024.
APA
Breuer, A., Haj, C. G., Fogaça, M. V., Gomes, F. V., Silva, N. R., Pedrazzi, J. F., et al. (2016). Correction: Fluorinated cannabidiol derivatives: enhancement of activity in mice models predictive of anxiolytic, antidepressant and antipsychotic effects. PLOS ONE, 11( 8). doi:10.1371/journal.pone.0162087
NLM
Breuer A, Haj CG, Fogaça MV, Gomes FV, Silva NR, Pedrazzi JF, Del Bel EA, Hallak JEC, Crippa JA de S, Zuardi AW, Mechoulam R, Guimarães FS. Correction: Fluorinated cannabidiol derivatives: enhancement of activity in mice models predictive of anxiolytic, antidepressant and antipsychotic effects [Internet]. PLOS ONE. 2016 ; 11( 8):[citado 2024 out. 31 ] Available from: https://doi.org/10.1371/journal.pone.0162087
Vancouver
Breuer A, Haj CG, Fogaça MV, Gomes FV, Silva NR, Pedrazzi JF, Del Bel EA, Hallak JEC, Crippa JA de S, Zuardi AW, Mechoulam R, Guimarães FS. Correction: Fluorinated cannabidiol derivatives: enhancement of activity in mice models predictive of anxiolytic, antidepressant and antipsychotic effects [Internet]. PLOS ONE. 2016 ; 11( 8):[citado 2024 out. 31 ] Available from: https://doi.org/10.1371/journal.pone.0162087
Artigo de periodico
Cannabidiol prevents motor and cognitive impairments induced by reserpine in rats (2016)
Peres, Fernanda F.; Levin, Raquel; Suiama, Mayra A.; Diana, Mariana C.; Gouvêa, Douglas A.; Almeida, Valéria; Santos, Camila M.; Lungato, Lisandro; Zuardi, Antônio Waldo; Hallak, Jaime Eduardo Cecílio; Crippa, José Alexandre de Souza; D’Almeida, Vânia; Silva, Regina H.; Abílio, Vanessa C.
Source: Frontiers in Pharmacology. Unidade: FMRP
Subjects: CANABINOIDES, DOENÇA DE PARKINSON, ESQUIZOFRENIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PERES, Fernanda F. et al. Cannabidiol prevents motor and cognitive impairments induced by reserpine in rats. Frontiers in Pharmacology, v. 7, 2016Tradução . . Disponível em: https://doi.org/10.3389/fphar.2016.00343. Acesso em: 31 out. 2024.
APA
Peres, F. F., Levin, R., Suiama, M. A., Diana, M. C., Gouvêa, D. A., Almeida, V., et al. (2016). Cannabidiol prevents motor and cognitive impairments induced by reserpine in rats. Frontiers in Pharmacology, 7. doi:10.3389/fphar.2016.00343
NLM
Peres FF, Levin R, Suiama MA, Diana MC, Gouvêa DA, Almeida V, Santos CM, Lungato L, Zuardi AW, Hallak JEC, Crippa JA de S, D’Almeida V, Silva RH, Abílio VC. Cannabidiol prevents motor and cognitive impairments induced by reserpine in rats [Internet]. Frontiers in Pharmacology. 2016 ; 7[citado 2024 out. 31 ] Available from: https://doi.org/10.3389/fphar.2016.00343
Vancouver
Peres FF, Levin R, Suiama MA, Diana MC, Gouvêa DA, Almeida V, Santos CM, Lungato L, Zuardi AW, Hallak JEC, Crippa JA de S, D’Almeida V, Silva RH, Abílio VC. Cannabidiol prevents motor and cognitive impairments induced by reserpine in rats [Internet]. Frontiers in Pharmacology. 2016 ; 7[citado 2024 out. 31 ] Available from: https://doi.org/10.3389/fphar.2016.00343
Artigo de periodico-carta/editorial
Peripubertal treatment with cannabidiol prevents the emergence of psychosis in an animal model of schizophrenia. [Carta] (2016)
Peres, F. F; Diana, M. C; Suiama, M. A; Justi, V; Almeida, V; Bressan, R. A; Zuardi, Antonio Waldo; Hallak, Jaime Eduardo Cecílio; Crippa, José Alexandre de Souza; Abilio, V. C
Source: Schizophrenia Research. Unidade: FMRP
Subjects: ESQUIZOFRENIA, MODELOS ANIMAIS, FÁRMACOS PSICOTRÓPICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PERES, F. F et al. Peripubertal treatment with cannabidiol prevents the emergence of psychosis in an animal model of schizophrenia. [Carta]. Schizophrenia Research. Amsterdam: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/j.schres.2016.02.004. Acesso em: 31 out. 2024. , 2016
APA
Peres, F. F., Diana, M. C., Suiama, M. A., Justi, V., Almeida, V., Bressan, R. A., et al. (2016). Peripubertal treatment with cannabidiol prevents the emergence of psychosis in an animal model of schizophrenia. [Carta]. Schizophrenia Research. Amsterdam: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1016/j.schres.2016.02.004
NLM
Peres FF, Diana MC, Suiama MA, Justi V, Almeida V, Bressan RA, Zuardi AW, Hallak JEC, Crippa JA de S, Abilio VC. Peripubertal treatment with cannabidiol prevents the emergence of psychosis in an animal model of schizophrenia. [Carta] [Internet]. Schizophrenia Research. 2016 ; 172( 1-3): 220-221.[citado 2024 out. 31 ] Available from: https://doi.org/10.1016/j.schres.2016.02.004
Vancouver
Peres FF, Diana MC, Suiama MA, Justi V, Almeida V, Bressan RA, Zuardi AW, Hallak JEC, Crippa JA de S, Abilio VC. Peripubertal treatment with cannabidiol prevents the emergence of psychosis in an animal model of schizophrenia. [Carta] [Internet]. Schizophrenia Research. 2016 ; 172( 1-3): 220-221.[citado 2024 out. 31 ] Available from: https://doi.org/10.1016/j.schres.2016.02.004
Artigo de periodico
Δ9-THC intoxication by cannabidiol-enriched cannabis extract in two children with refractory epilepsy: full remission after switching to purified cannabidiol (2016)
Crippa, José Alexandre de Souza; Crippa, Ana C. S.; Hallak, Jaime Eduardo Cecílio; Martín-Santos, Rocio; Zuardi, Antônio Waldo
Source: Frontiers in Pharmacology. Unidade: FMRP
Subjects: CANABINOIDES, EPILEPSIA, ELETROFISIOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CRIPPA, José Alexandre de Souza et al. Δ9-THC intoxication by cannabidiol-enriched cannabis extract in two children with refractory epilepsy: full remission after switching to purified cannabidiol. Frontiers in Pharmacology, v. 7, 2016Tradução . . Disponível em: https://doi.org/10.3389/fphar.2016.00359. Acesso em: 31 out. 2024.
APA
Crippa, J. A. de S., Crippa, A. C. S., Hallak, J. E. C., Martín-Santos, R., & Zuardi, A. W. (2016). Δ9-THC intoxication by cannabidiol-enriched cannabis extract in two children with refractory epilepsy: full remission after switching to purified cannabidiol. Frontiers in Pharmacology, 7. doi:10.3389/fphar.2016.00359
NLM
Crippa JA de S, Crippa ACS, Hallak JEC, Martín-Santos R, Zuardi AW. Δ9-THC intoxication by cannabidiol-enriched cannabis extract in two children with refractory epilepsy: full remission after switching to purified cannabidiol [Internet]. Frontiers in Pharmacology. 2016 ; 7[citado 2024 out. 31 ] Available from: https://doi.org/10.3389/fphar.2016.00359
Vancouver
Crippa JA de S, Crippa ACS, Hallak JEC, Martín-Santos R, Zuardi AW. Δ9-THC intoxication by cannabidiol-enriched cannabis extract in two children with refractory epilepsy: full remission after switching to purified cannabidiol [Internet]. Frontiers in Pharmacology. 2016 ; 7[citado 2024 out. 31 ] Available from: https://doi.org/10.3389/fphar.2016.00359
Artigo de periodico
Fluorinated Cannabidiol derivatives: enhancement of Activity in Mice Models Predictive of Anxiolytic, Antidepressant and Antipsychotic Effects (2016)
Breuer, Aviva; Haj, Christeene G.; Fogaça, Manoela V.; Gomes, Felipe V.; Silva, Nicole Rodrigues; Pedrazzi, João Francisco; Del Bel, Elaine Aparecida; Hallak, Jaime Eduardo Cecílio; Crippa, José Alexandre de Souza; Zuardi, Antônio Waldo; Mechoulam, Raphael; Guimarães, Francisco Silveira
Source: PLoS ONE. Unidades: FORP, FMRP
Subjects: CANABINOIDES, FLUORAÇÃO, NEUROPSIQUIATRIA, FARMACOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BREUER, Aviva et al. Fluorinated Cannabidiol derivatives: enhancement of Activity in Mice Models Predictive of Anxiolytic, Antidepressant and Antipsychotic Effects. PLoS ONE, v. 11, 2016Tradução . . Disponível em: https://doi.org/10.1371/journal.pone.0158779. Acesso em: 31 out. 2024.
APA
Breuer, A., Haj, C. G., Fogaça, M. V., Gomes, F. V., Silva, N. R., Pedrazzi, J. F., et al. (2016). Fluorinated Cannabidiol derivatives: enhancement of Activity in Mice Models Predictive of Anxiolytic, Antidepressant and Antipsychotic Effects. PLoS ONE, 11. doi:10.1371/journal.pone.0158779
NLM
Breuer A, Haj CG, Fogaça MV, Gomes FV, Silva NR, Pedrazzi JF, Del Bel EA, Hallak JEC, Crippa JA de S, Zuardi AW, Mechoulam R, Guimarães FS. Fluorinated Cannabidiol derivatives: enhancement of Activity in Mice Models Predictive of Anxiolytic, Antidepressant and Antipsychotic Effects [Internet]. PLoS ONE. 2016 ; 11[citado 2024 out. 31 ] Available from: https://doi.org/10.1371/journal.pone.0158779
Vancouver
Breuer A, Haj CG, Fogaça MV, Gomes FV, Silva NR, Pedrazzi JF, Del Bel EA, Hallak JEC, Crippa JA de S, Zuardi AW, Mechoulam R, Guimarães FS. Fluorinated Cannabidiol derivatives: enhancement of Activity in Mice Models Predictive of Anxiolytic, Antidepressant and Antipsychotic Effects [Internet]. PLoS ONE. 2016 ; 11[citado 2024 out. 31 ] Available from: https://doi.org/10.1371/journal.pone.0158779
Artigo de periodico
Cannabidiol, among other cannabinoid drugs, modulates prepulse inhibition of startle in the SHR animal model: implications for schizophrenia pharmacotherapy (2016)
Peres, Fernanda F.; Levin, Raquel; Almeida, Valéria; Zuardi, Antônio Waldo; Hallak, Jaime Eduardo Cecílio; Crippa, José Alexandre de Souza; Abilio, Vanessa C.
Source: Frontiers in Pharmacology. Unidade: FMRP
Subjects: CANABINOIDES, MODELOS ANIMAIS, ESQUIZOFRENIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PERES, Fernanda F. et al. Cannabidiol, among other cannabinoid drugs, modulates prepulse inhibition of startle in the SHR animal model: implications for schizophrenia pharmacotherapy. Frontiers in Pharmacology, v. 7, 2016Tradução . . Disponível em: https://doi.org/10.3389/fphar.2016.00303. Acesso em: 31 out. 2024.
APA
Peres, F. F., Levin, R., Almeida, V., Zuardi, A. W., Hallak, J. E. C., Crippa, J. A. de S., & Abilio, V. C. (2016). Cannabidiol, among other cannabinoid drugs, modulates prepulse inhibition of startle in the SHR animal model: implications for schizophrenia pharmacotherapy. Frontiers in Pharmacology, 7. doi:10.3389/fphar.2016.00303
NLM
Peres FF, Levin R, Almeida V, Zuardi AW, Hallak JEC, Crippa JA de S, Abilio VC. Cannabidiol, among other cannabinoid drugs, modulates prepulse inhibition of startle in the SHR animal model: implications for schizophrenia pharmacotherapy [Internet]. Frontiers in Pharmacology. 2016 ; 7[citado 2024 out. 31 ] Available from: https://doi.org/10.3389/fphar.2016.00303
Vancouver
Peres FF, Levin R, Almeida V, Zuardi AW, Hallak JEC, Crippa JA de S, Abilio VC. Cannabidiol, among other cannabinoid drugs, modulates prepulse inhibition of startle in the SHR animal model: implications for schizophrenia pharmacotherapy [Internet]. Frontiers in Pharmacology. 2016 ; 7[citado 2024 out. 31 ] Available from: https://doi.org/10.3389/fphar.2016.00303
Artigo de periodico-carta/editorial
The effects of sodium nitroprusside treatment on cognitive deficits in schizophrenia. [Carta]: a pilot study (2015)
Maia-de-Oliveira, João Paulo; Abrão, João; Evora, Paulo Roberto Barbosa; Zuardi, Antonio Waldo; Crippa, José Alexandre de Souza; Belmonte-de-Abreu, Paulo; Baker, Glen B; Dursun, Serdar M; Hallak, Jaime Eduardo Cecílio
Source: Journal of Clinical Psychopharmacology. Unidade: FMRP
Subjects: TRANSTORNOS COGNITIVOS (DIAGNÓSTICO), ÓXIDO NÍTRICO (FARMACOLOGIA), ESQUIZOFRENIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MAIA-DE-OLIVEIRA, João Paulo et al. The effects of sodium nitroprusside treatment on cognitive deficits in schizophrenia. [Carta]: a pilot study. Journal of Clinical Psychopharmacology. Philadelphia: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1097/JCP.0000000000000258. Acesso em: 31 out. 2024. , 2015
APA
Maia-de-Oliveira, J. P., Abrão, J., Evora, P. R. B., Zuardi, A. W., Crippa, J. A. de S., Belmonte-de-Abreu, P., et al. (2015). The effects of sodium nitroprusside treatment on cognitive deficits in schizophrenia. [Carta]: a pilot study. Journal of Clinical Psychopharmacology. Philadelphia: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1097/JCP.0000000000000258
NLM
Maia-de-Oliveira JP, Abrão J, Evora PRB, Zuardi AW, Crippa JA de S, Belmonte-de-Abreu P, Baker GB, Dursun SM, Hallak JEC. The effects of sodium nitroprusside treatment on cognitive deficits in schizophrenia. [Carta]: a pilot study [Internet]. Journal of Clinical Psychopharmacology. 2015 ; 35( 1): 83-85.[citado 2024 out. 31 ] Available from: https://doi.org/10.1097/JCP.0000000000000258
Vancouver
Maia-de-Oliveira JP, Abrão J, Evora PRB, Zuardi AW, Crippa JA de S, Belmonte-de-Abreu P, Baker GB, Dursun SM, Hallak JEC. The effects of sodium nitroprusside treatment on cognitive deficits in schizophrenia. [Carta]: a pilot study [Internet]. Journal of Clinical Psychopharmacology. 2015 ; 35( 1): 83-85.[citado 2024 out. 31 ] Available from: https://doi.org/10.1097/JCP.0000000000000258
Artigo de periodico
Caffeine protects against memory loss induced by high and non-anxiolytic dose of cannabidiol in adult zebrafish (Danio rerio) (2015)
Nazario, Luiza Reali; Antonioli Junior, Régis; Capiotti, Katiucia Marques; Hallak, Jaime Eduardo Cecílio; Zuardi, Antonio Waldo; Crippa, José Alexandre de Souza; Bonan, Carla Denise; Silva, Rosane Souza da
Source: Pharmacology, Biochemistry and Behavior. Unidade: FMRP
Subjects: ADENOSINA, ANSIEDADE, CAFEÍNA, CANABINOIDES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NAZARIO, Luiza Reali et al. Caffeine protects against memory loss induced by high and non-anxiolytic dose of cannabidiol in adult zebrafish (Danio rerio). Pharmacology, Biochemistry and Behavior, v. 135, p. 210-216, 2015Tradução . . Disponível em: https://doi.org/10.1016/j.pbb.2015.06.008. Acesso em: 31 out. 2024.
APA
Nazario, L. R., Antonioli Junior, R., Capiotti, K. M., Hallak, J. E. C., Zuardi, A. W., Crippa, J. A. de S., et al. (2015). Caffeine protects against memory loss induced by high and non-anxiolytic dose of cannabidiol in adult zebrafish (Danio rerio). Pharmacology, Biochemistry and Behavior, 135, 210-216. doi:10.1016/j.pbb.2015.06.008
NLM
Nazario LR, Antonioli Junior R, Capiotti KM, Hallak JEC, Zuardi AW, Crippa JA de S, Bonan CD, Silva RS da. Caffeine protects against memory loss induced by high and non-anxiolytic dose of cannabidiol in adult zebrafish (Danio rerio) [Internet]. Pharmacology, Biochemistry and Behavior. 2015 ; 135 210-216.[citado 2024 out. 31 ] Available from: https://doi.org/10.1016/j.pbb.2015.06.008
Vancouver
Nazario LR, Antonioli Junior R, Capiotti KM, Hallak JEC, Zuardi AW, Crippa JA de S, Bonan CD, Silva RS da. Caffeine protects against memory loss induced by high and non-anxiolytic dose of cannabidiol in adult zebrafish (Danio rerio) [Internet]. Pharmacology, Biochemistry and Behavior. 2015 ; 135 210-216.[citado 2024 out. 31 ] Available from: https://doi.org/10.1016/j.pbb.2015.06.008
Artigo de periodico
Reprint of “Caffeine protects against memory loss induced by high and non-anxiolytic dose of cannabidiol in adult zebrafish (Danio rerio)” (2015)
Nazario, Luiza Reali; Antonioli Junior, Régis; Capiotti, Katiucia Marques; Hallak, Jaime Eduardo Cecílio; Zuardi, Antonio Waldo; Crippa, José Alexandre de Souza; Bonan, Carla Denise; Silva, Rosane Souza da
Source: Pharmacology, Biochemistry and Behavior. Unidade: FMRP
Subjects: ADENOSINA, ANSIEDADE, CAFEÍNA, CANABINOIDES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NAZARIO, Luiza Reali et al. Reprint of “Caffeine protects against memory loss induced by high and non-anxiolytic dose of cannabidiol in adult zebrafish (Danio rerio)”. Pharmacology, Biochemistry and Behavior, v. 203, p. 134-140, 2015Tradução . . Disponível em: https://doi.org/10.1016/j.pbb.2015.11.002. Acesso em: 31 out. 2024.
APA
Nazario, L. R., Antonioli Junior, R., Capiotti, K. M., Hallak, J. E. C., Zuardi, A. W., Crippa, J. A. de S., et al. (2015). Reprint of “Caffeine protects against memory loss induced by high and non-anxiolytic dose of cannabidiol in adult zebrafish (Danio rerio)”. Pharmacology, Biochemistry and Behavior, 203, 134-140. doi:10.1016/j.pbb.2015.11.002
NLM
Nazario LR, Antonioli Junior R, Capiotti KM, Hallak JEC, Zuardi AW, Crippa JA de S, Bonan CD, Silva RS da. Reprint of “Caffeine protects against memory loss induced by high and non-anxiolytic dose of cannabidiol in adult zebrafish (Danio rerio)” [Internet]. Pharmacology, Biochemistry and Behavior. 2015 ; 203 134-140.[citado 2024 out. 31 ] Available from: https://doi.org/10.1016/j.pbb.2015.11.002
Vancouver
Nazario LR, Antonioli Junior R, Capiotti KM, Hallak JEC, Zuardi AW, Crippa JA de S, Bonan CD, Silva RS da. Reprint of “Caffeine protects against memory loss induced by high and non-anxiolytic dose of cannabidiol in adult zebrafish (Danio rerio)” [Internet]. Pharmacology, Biochemistry and Behavior. 2015 ; 203 134-140.[citado 2024 out. 31 ] Available from: https://doi.org/10.1016/j.pbb.2015.11.002
Artigo de periodico
Cortical thinning of the right anterior cingulate cortex in spider phobia: a magnetic resonance imaging and spectroscopy study (2014)
Linares, I. M. P; Jackowski, A. P; Trzesniak, C. M. F; Arrais, K. C; Chagas, Marcos Hortes Nisihara; Sato, J. R; Santos, Antônio Carlos dos; Hallak, Jaime Eduardo Cecílio; Zuardi, Antonio Waldo; Nardi, A. E; Coimbra, Norberto Cysne; Crippa, José Alexandre de Souza
Source: Brain Research. Unidade: FMRP
Subjects: FOBIAS (ESPECIFICAÇÃO), ANSIEDADE, MEDO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LINARES, I. M. P et al. Cortical thinning of the right anterior cingulate cortex in spider phobia: a magnetic resonance imaging and spectroscopy study. Brain Research, v. 1576, p. 35-42, 2014Tradução . . Disponível em: https://doi.org/10.1016/j.brainres.2014.05.040. Acesso em: 31 out. 2024.
APA
Linares, I. M. P., Jackowski, A. P., Trzesniak, C. M. F., Arrais, K. C., Chagas, M. H. N., Sato, J. R., et al. (2014). Cortical thinning of the right anterior cingulate cortex in spider phobia: a magnetic resonance imaging and spectroscopy study. Brain Research, 1576, 35-42. doi:10.1016/j.brainres.2014.05.040
NLM
Linares IMP, Jackowski AP, Trzesniak CMF, Arrais KC, Chagas MHN, Sato JR, Santos AC dos, Hallak JEC, Zuardi AW, Nardi AE, Coimbra NC, Crippa JA de S. Cortical thinning of the right anterior cingulate cortex in spider phobia: a magnetic resonance imaging and spectroscopy study [Internet]. Brain Research. 2014 ; 1576 35-42.[citado 2024 out. 31 ] Available from: https://doi.org/10.1016/j.brainres.2014.05.040
Vancouver
Linares IMP, Jackowski AP, Trzesniak CMF, Arrais KC, Chagas MHN, Sato JR, Santos AC dos, Hallak JEC, Zuardi AW, Nardi AE, Coimbra NC, Crippa JA de S. Cortical thinning of the right anterior cingulate cortex in spider phobia: a magnetic resonance imaging and spectroscopy study [Internet]. Brain Research. 2014 ; 1576 35-42.[citado 2024 out. 31 ] Available from: https://doi.org/10.1016/j.brainres.2014.05.040
Artigo de periodico
Oxytocin does not improve performance of patients with schizophrenia and healthy volunteers in a facial emotion matching task (2014)
Macedo, Ligia R. Horta de; Zuardi, Antonio Waldo; Machado-de-Sousa, João Paulo; Chagas, Marcos Hortes Nisihara; Hallak, Jaime Eduardo Cecílio
Source: Psychiatry Research. Unidade: FMRP
Subjects: NEUROPEPTÍDEOS, EMOÇÕES, COGNIÇÃO SOCIAL, OCITOCINA, ESQUIZOFRENIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MACEDO, Ligia R. Horta de et al. Oxytocin does not improve performance of patients with schizophrenia and healthy volunteers in a facial emotion matching task. Psychiatry Research, v. 220, n. 1-2, p. 125-128, 2014Tradução . . Disponível em: https://doi.org/10.1016/j.psychres.2014.07.082. Acesso em: 31 out. 2024.
APA
Macedo, L. R. H. de, Zuardi, A. W., Machado-de-Sousa, J. P., Chagas, M. H. N., & Hallak, J. E. C. (2014). Oxytocin does not improve performance of patients with schizophrenia and healthy volunteers in a facial emotion matching task. Psychiatry Research, 220( 1-2), 125-128. doi:10.1016/j.psychres.2014.07.082
NLM
Macedo LRH de, Zuardi AW, Machado-de-Sousa JP, Chagas MHN, Hallak JEC. Oxytocin does not improve performance of patients with schizophrenia and healthy volunteers in a facial emotion matching task [Internet]. Psychiatry Research. 2014 ; 220( 1-2): 125-128.[citado 2024 out. 31 ] Available from: https://doi.org/10.1016/j.psychres.2014.07.082
Vancouver
Macedo LRH de, Zuardi AW, Machado-de-Sousa JP, Chagas MHN, Hallak JEC. Oxytocin does not improve performance of patients with schizophrenia and healthy volunteers in a facial emotion matching task [Internet]. Psychiatry Research. 2014 ; 220( 1-2): 125-128.[citado 2024 out. 31 ] Available from: https://doi.org/10.1016/j.psychres.2014.07.082
Artigo de periodico
Rapid improvement of acute schizophrenia symptoms after intravenous sodium nitroprusside: a randomized, double-blind, placebo-controlled trial (2013)
Hallak, Jaime Eduardo Cecílio; Maia-de-Oliveira, João Paulo; Abrão, João; Evora, Paulo Roberto Barbosa; Zuardi, Antonio Waldo; Crippa, José Alexandre de Souza; Belmonte-de-Abreu, Paulo; Baker, Glen B.; Dursun, Serdar M.
Source: JAMA Psychiatry. Unidade: FMRP
Subjects: ESQUIZOFRENIA, MEDICAÇÃO INTRAVENOSA, ANTIPSICÓTICOS, MÉTODO DUPLO-CEGO, PLACEBOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HALLAK, Jaime Eduardo Cecílio et al. Rapid improvement of acute schizophrenia symptoms after intravenous sodium nitroprusside: a randomized, double-blind, placebo-controlled trial. JAMA Psychiatry, v. 70, n. 7, p. 668-676, 2013Tradução . . Disponível em: https://doi.org/10.1001/jamapsychiatry.2013.1292. Acesso em: 31 out. 2024.
APA
Hallak, J. E. C., Maia-de-Oliveira, J. P., Abrão, J., Evora, P. R. B., Zuardi, A. W., Crippa, J. A. de S., et al. (2013). Rapid improvement of acute schizophrenia symptoms after intravenous sodium nitroprusside: a randomized, double-blind, placebo-controlled trial. JAMA Psychiatry, 70( 7), 668-676. doi:10.1001/jamapsychiatry.2013.1292
NLM
Hallak JEC, Maia-de-Oliveira JP, Abrão J, Evora PRB, Zuardi AW, Crippa JA de S, Belmonte-de-Abreu P, Baker GB, Dursun SM. Rapid improvement of acute schizophrenia symptoms after intravenous sodium nitroprusside: a randomized, double-blind, placebo-controlled trial [Internet]. JAMA Psychiatry. 2013 ; 70( 7): 668-676.[citado 2024 out. 31 ] Available from: https://doi.org/10.1001/jamapsychiatry.2013.1292
Vancouver
Hallak JEC, Maia-de-Oliveira JP, Abrão J, Evora PRB, Zuardi AW, Crippa JA de S, Belmonte-de-Abreu P, Baker GB, Dursun SM. Rapid improvement of acute schizophrenia symptoms after intravenous sodium nitroprusside: a randomized, double-blind, placebo-controlled trial [Internet]. JAMA Psychiatry. 2013 ; 70( 7): 668-676.[citado 2024 out. 31 ] Available from: https://doi.org/10.1001/jamapsychiatry.2013.1292
Artigo de periodico
Cannabidiol for the treatment of cannabis withdrawal syndrome: a case report (2013)
Crippa, José Alexandre de Souza; Hallak, Jaime Eduardo Cecílio; Machado-de-Sousa, J. P; Queiroz, Regina Helena Costa; Bergamaschi, M; Chagas, Marcos Hortes Nisihara; Zuardi, Antonio Waldo
Source: Journal of Clinical Pharmacy and Therapeutics. Unidades: FMRP, FCFRP
Subjects: CANNABIS (APLICAÇÕES TERAPÊUTICAS;EFEITOS ADVERSOS), TRANSTORNOS RELACIONADOS AO USO DE SUBSTÂNCIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CRIPPA, José Alexandre de Souza et al. Cannabidiol for the treatment of cannabis withdrawal syndrome: a case report. Journal of Clinical Pharmacy and Therapeutics, v. 38, n. 2, p. 162-164, 2013Tradução . . Disponível em: https://doi.org/10.1111/jcpt.12018. Acesso em: 31 out. 2024.
APA
Crippa, J. A. de S., Hallak, J. E. C., Machado-de-Sousa, J. P., Queiroz, R. H. C., Bergamaschi, M., Chagas, M. H. N., & Zuardi, A. W. (2013). Cannabidiol for the treatment of cannabis withdrawal syndrome: a case report. Journal of Clinical Pharmacy and Therapeutics, 38( 2), 162-164. doi:10.1111/jcpt.12018
NLM
Crippa JA de S, Hallak JEC, Machado-de-Sousa JP, Queiroz RHC, Bergamaschi M, Chagas MHN, Zuardi AW. Cannabidiol for the treatment of cannabis withdrawal syndrome: a case report [Internet]. Journal of Clinical Pharmacy and Therapeutics. 2013 ; 38( 2): 162-164.[citado 2024 out. 31 ] Available from: https://doi.org/10.1111/jcpt.12018
Vancouver
Crippa JA de S, Hallak JEC, Machado-de-Sousa JP, Queiroz RHC, Bergamaschi M, Chagas MHN, Zuardi AW. Cannabidiol for the treatment of cannabis withdrawal syndrome: a case report [Internet]. Journal of Clinical Pharmacy and Therapeutics. 2013 ; 38( 2): 162-164.[citado 2024 out. 31 ] Available from: https://doi.org/10.1111/jcpt.12018
Artigo de periodico
Effects of acute systemic administration of cannabidiol on sleep-wake cycle in rats (2013)
Chagas, Marcos Hortes Nisihara; Crippa, José Alexandre de Souza; Zuardi, Antonio Waldo; Hallak, Jaime Eduardo Cecílio; Machado-de-Sousa, João Paulo; Hirotsu, Camila; Maia, Lucas; Tufik, Sergio; Andersen, Monica Levy
Source: Journal of Psychopharmacology. Unidade: FMRP
Subjects: ANTIDEPRESSIVOS (FARMACOLOGIA), CANNABIS (COMPONENTES), SONO (EFEITOS DE DROGAS), HIPNÓTICOS, SEDATIVOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CHAGAS, Marcos Hortes Nisihara et al. Effects of acute systemic administration of cannabidiol on sleep-wake cycle in rats. Journal of Psychopharmacology, v. 27, n. 3, p. 312-316, 2013Tradução . . Disponível em: https://doi.org/10.1177/0269881112474524. Acesso em: 31 out. 2024.
APA
Chagas, M. H. N., Crippa, J. A. de S., Zuardi, A. W., Hallak, J. E. C., Machado-de-Sousa, J. P., Hirotsu, C., et al. (2013). Effects of acute systemic administration of cannabidiol on sleep-wake cycle in rats. Journal of Psychopharmacology, 27( 3), 312-316. doi:10.1177/0269881112474524
NLM
Chagas MHN, Crippa JA de S, Zuardi AW, Hallak JEC, Machado-de-Sousa JP, Hirotsu C, Maia L, Tufik S, Andersen ML. Effects of acute systemic administration of cannabidiol on sleep-wake cycle in rats [Internet]. Journal of Psychopharmacology. 2013 ; 27( 3): 312-316.[citado 2024 out. 31 ] Available from: https://doi.org/10.1177/0269881112474524
Vancouver
Chagas MHN, Crippa JA de S, Zuardi AW, Hallak JEC, Machado-de-Sousa JP, Hirotsu C, Maia L, Tufik S, Andersen ML. Effects of acute systemic administration of cannabidiol on sleep-wake cycle in rats [Internet]. Journal of Psychopharmacology. 2013 ; 27( 3): 312-316.[citado 2024 out. 31 ] Available from: https://doi.org/10.1177/0269881112474524

USP Schools

ReP

Filtros

Departament

Authors

USP affiliated authors

Subjects

Source title

Countries/Territories

Funding Agencies

Indexado em

Non normalized affiliation